Repairing scars with tissue-engineered skin grafts

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on treating hypertrophic scars, which can lead to reduced quality of life and joint dysfunction. It aims to utilize tissue-engineered skin grafts made from autologous scar dermal scaffolds to improve scar repair outcomes. The approach seeks to address the limitations of current skin grafting methods, such as insufficient skin sources and high recurrence rates. By using the patient's own cells, the study hopes to enhance the survival rate of the grafts and reduce medical costs associated with scar treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

The patient is diagnosed as hypertrophic scar and needs surgical repair; The scar size was 10cm2 to 200cm2, and the site was not limited; Patients with stable vital signs and tolerable operation indicated by routine examination; Patients in good mental state, can follow the doctor's advice, regular return; Those whom the researchers considered unsuitable for inclusion; Patients have participated in this study at any time in the past; Those whom the researchers considered unsuitable for inclusion; Patients have participated in this study at any time in the past.

Exclusion Criteria:

Those who did not meet the inclusion criteria were found after the selected subjects; The follow-up time after inclusion was less than 2 times, and the objective efficacy could not be evaluated (but the adverse reactions could be evaluated); Subjects who violate protocol requirements.

Where it's running

• The First Affiliated Hospital, Sun Yat-sen University
  Guangzhou, Guangdong, China Recruiting

Study contacts

• Study coordinator: Zhu Jiayuan
• Email: zhujiay@mail.sysu.edu.cn
• Phone: 86-20-87755766

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Disposable noninvasive skin closure to help healing and reduce scarring after plastic surgery

  This study tests a disposable noninvasive skin closure device on one side of a plastic surgery incision to see if it helps wounds heal better and results in less scarring.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT07849010

• Phase II test of 9MW3811 for pathological scars

  This trial will try injections of 9MW3811 to see if they improve pathological scars in adults compared with placebo.

  Recruiting Phase 2 Mabwell (Shanghai) Bioscience Co., Ltd. · Shanghai, Shanghai Municipality · NCT07576608

• Myofascial release versus deep friction massage for C-section scar healing and abdominal recovery

  This study will test whether myofascial release or deep friction massage helps women with long-term C-section scar pain improve abdominal recovery and scar symptoms.

  Recruiting Cairo University · Alexandria · NCT07130747

• Effects of shock wave therapy on surgical scars

  This study is testing whether shock wave therapy can help improve the appearance and symptoms of surgical scars in patients who have had procedures like tummy tucks and breast reductions.

  Recruiting at 4 sites Universiteit Antwerpen · Antwerp, Antwerp and 3 other locations · NCT06825039

• Paraffin Wax plus Exercise for Improving Joint Movement in Burn Scars

  This study will test whether adding paraffin wax to exercise-based scar rehab helps adults with burn scars that cross a joint improve joint range of motion and function.

  Recruiting Medstar Health Research Institute · Washington D.C., District of Columbia · NCT06786884

• Hyaluronic acid plus recombinant collagen volumizing filler for facial wrinkles and sagging

  This trial will try a hyaluronic acid and recombinant collagen filler to reduce facial wrinkles, scars, and tissue laxity in non-smoking adults aged 18–70.

  Recruiting Taumedika s.r.l. · Roma · NCT06336044

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.